Acurx Pharmaceuticals Inc
(ACXP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 14,103 | 14,578 | 12,093 | 12,814 | 4,600 |
| Operating Income | -14,103 | -14,578 | -12,093 | -12,814 | -4,600 |
| Other Income | 0 | 0 | 0 | 67 | 0 |
| Pre-tax Income | -14,103 | -14,578 | -12,093 | -12,748 | -4,600 |
| Net Income Continuous | -14,103 | -14,578 | -12,093 | -12,748 | -4,600 |
| Net Income | $-14,103 | $-14,578 | $-12,093 | $-12,748 | $-4,600 |
| EPS Basic Total Ops | -17.40 | -23.00 | -22.40 | -29.80 | -14.80 |
| EPS Basic Continuous Ops | -17.45 | -23.01 | -22.36 | -29.87 | -14.86 |
| EPS Diluted Total Ops | -17.40 | -23.00 | -22.40 | -29.80 | -14.80 |
| EPS Diluted Continuous Ops | -17.45 | -23.01 | -22.36 | -29.87 | -14.86 |
| EPS Diluted Before Non-Recurring Items | -17.40 | -23.00 | -22.40 | -29.80 | N/A |
| EBITDA(a) | $-14,103 | $-14,578 | $-12,093 | $-12,814 | $-4,600 |